This page has only limited features, please log in for full access.

Unclaimed
João Pereira
NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal

Basic Info

Basic Info is private.

Honors and Awards

The user has no records in this section


Career Timeline

The user has no records in this section.


Short Biography

The user biography is not available.
Following
Followers
Co Authors
The list of users this user is following is empty.
Following: 0 users

Feed

Research article
Published: 21 June 2021 in Portuguese Journal of Public Health
Reads 0
Downloads 0

Introduction: Health technology assessment (HTA) aims to provide decision makers with relevant data to make informed choices. Recent changes in the Portuguese HTA framework have altered substantially the assessment methodology with regard to economic evaluation, with potential impacts on access and process efficiency. The HTA Reshaping Project had as its main objective informing the debate on HTA in Portugal, thereby identifying improvement opportunities and solutions to the HTA framework that address future challenges. Methods: The project comprised several phases, i.e., (1) mapping and evaluation of different HTA frameworks across Europe, identifying best practices and key variables to consider in future frameworks; (2) conduction of in-depth interviews with relevant stakeholders (n = 11); and (3) development of 2 workshops – one with young professionals (n = 12) and another with relevant HTA stakeholders (n = 19) – to consolidate and further explore vital elements of HTA, aimed at brainstorming ideas and developing solutions to improve some of the most critical points, with a view to addressing future challenges. Results: The comparison of HTA frameworks showed that their purpose and sophistication vary across European countries. For example, the need for economic evidence is not unanimous, and reimbursement agreements vary considerably. Among the stakeholders interviewed there was a high level of agreement on priorities that should be addressed, e.g., expanding and creating national level registries and assuring patient participation throughout the HTA process. The possibility of using managed entry agreements to enhance patients’ access, applying multi-indication pricing for medicines with different therapeutic values per indication, and improvement of registry/system interoperability gathered a moderate level of agreement. Conclusions: The Portuguese HTA framework might be further adapted to upcoming challenges and should evolve to improve access to innovative therapies. There is still a long path towards the convergence of HTA frameworks in EU member states.

ACS Style

João Pereira; Joana Alves; Bernardo Rodrigues; Ricardo Caetano; Pedro Brito-Cruz; Joana Sousa; Branca Barata. HTA Reshaping: Rethinking the Health Technology Assessment Framework in Portugal. Portuguese Journal of Public Health 2021, 39, 36 -47.

AMA Style

João Pereira, Joana Alves, Bernardo Rodrigues, Ricardo Caetano, Pedro Brito-Cruz, Joana Sousa, Branca Barata. HTA Reshaping: Rethinking the Health Technology Assessment Framework in Portugal. Portuguese Journal of Public Health. 2021; 39 (1):36-47.

Chicago/Turabian Style

João Pereira; Joana Alves; Bernardo Rodrigues; Ricardo Caetano; Pedro Brito-Cruz; Joana Sousa; Branca Barata. 2021. "HTA Reshaping: Rethinking the Health Technology Assessment Framework in Portugal." Portuguese Journal of Public Health 39, no. 1: 36-47.

Journal article
Published: 25 November 2020 in Sustainability
Reads 0
Downloads 0

Home respiratory care (HRC) is the provision of healthcare services at the place of residence of patients or their families, with the aim of meeting needs mainly resulting from chronic respiratory conditions, permanent disability, or terminal illness. In 2016, an innovative electronic prescription system, PEM-CRD, was fully implemented for HRC services in Portugal. To date, no study has addressed the impact of the execution of this digital innovation. For this purpose, we carried out an analysis of the prevalence and number of prescriptions for people with chronic respiratory diseases receiving HRC in the Lisbon metropolitan area, during 2014–2018, using the information obtained from the PEM-CRD database. The data analysis shows that while the number of patients receiving HRC treatment with a prescription has remained stable over the last four years, the number of prescriptions has significantly dropped since 2016 (2016–2018), with consequent paper and processes efficiency. The implementation of the digital Medical Electronic Prescription for Home Respiratory Care tool (PEM-CRD) and consequent dematerialization of these processes has increased the efficiency of prescribing in HRC. Additionally, the possibility of obtaining data through the PEM-CRD allows the monitoring of the evolving prevalence of therapies, improving the health services optimization and allowing reporting on data other than medicines.

ACS Style

Ricardo Alves; Cátia Caneiras; Ana Santos; Patricia Barbosa; João Cardoso; Paulo Caseiro; Maria Vitorino; João Pereira; Ana Escoval. Medical Electronic Prescription for Home Respiratory Care Services (PEM-CRD) at a Portuguese University Tertiary Care Centre (2014–2018): A Case Study. Sustainability 2020, 12, 9859 .

AMA Style

Ricardo Alves, Cátia Caneiras, Ana Santos, Patricia Barbosa, João Cardoso, Paulo Caseiro, Maria Vitorino, João Pereira, Ana Escoval. Medical Electronic Prescription for Home Respiratory Care Services (PEM-CRD) at a Portuguese University Tertiary Care Centre (2014–2018): A Case Study. Sustainability. 2020; 12 (23):9859.

Chicago/Turabian Style

Ricardo Alves; Cátia Caneiras; Ana Santos; Patricia Barbosa; João Cardoso; Paulo Caseiro; Maria Vitorino; João Pereira; Ana Escoval. 2020. "Medical Electronic Prescription for Home Respiratory Care Services (PEM-CRD) at a Portuguese University Tertiary Care Centre (2014–2018): A Case Study." Sustainability 12, no. 23: 9859.

Journal article
Published: 06 December 2018 in Portuguese Journal of Public Health
Reads 0
Downloads 0

Em vários países pelo mundo fora, estudos de avaliação económica são usados para informar o processo de decisão sobre novos produtos farmacêuticos e outras tecnologias da saúde, sobretudo a questão do seu financiamento por sistemas públicos. As autoridades desses países normalmente emitem orientações metodológicas sobre a elaboração dos estudos, sendo as orientações genericamente muito semelhantes entre países com diferenças apenas nos detalhes [1].

ACS Style

João A. Pereira. Revisão das orientações metodológicas de estudos de avaliação económica de medicamentos em Portugal. Portuguese Journal of Public Health 2018, 36, 1 -3.

AMA Style

João A. Pereira. Revisão das orientações metodológicas de estudos de avaliação económica de medicamentos em Portugal. Portuguese Journal of Public Health. 2018; 36 (1):1-3.

Chicago/Turabian Style

João A. Pereira. 2018. "Revisão das orientações metodológicas de estudos de avaliação económica de medicamentos em Portugal." Portuguese Journal of Public Health 36, no. 1: 1-3.

Journal article
Published: 13 April 2018 in Portuguese Journal of Public Health
Reads 0
Downloads 0

Welcome to the first issue of the Portuguese Journal of Public Health (PJPH). The journal takes up the legacy of the Revista Portuguesa de Saúde Pública (RPSP), a Portuguese-language journal, published since 1983, in the area of public health.

ACS Style

João Pereira; Helena Canhão. The Portuguese Journal of Public Health – A New Direction. Portuguese Journal of Public Health 2018, 35, 1 -2.

AMA Style

João Pereira, Helena Canhão. The Portuguese Journal of Public Health – A New Direction. Portuguese Journal of Public Health. 2018; 35 (1):1-2.

Chicago/Turabian Style

João Pereira; Helena Canhão. 2018. "The Portuguese Journal of Public Health – A New Direction." Portuguese Journal of Public Health 35, no. 1: 1-2.

Journal article
Published: 05 February 2018 in Journal of Bone Oncology
Reads 0
Downloads 0

Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer and can lead to debilitating complications (skeletal-related events [SREs]), including requirement for radiation to bone. Despite the high frequency of radiation to bone in patients with metastatic bone disease, our knowledge of associated healthcare resource utilization (HRU) is limited. This retrospective study estimated HRU following radiation to bone in Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden and Switzerland. Eligible patients were ≥ 20 years old, had bone metastases secondary to breast, lung or prostate cancer, or bone lesions associated with multiple myeloma, and had received radiation to bone between 1 July 2004 and 1 July 2009. HRU data were extracted from hospital patient charts from 3.5 months before the index SRE (radiation to bone preceded by a SRE-free period of ≥ 6.5 months) until 3 months after the last SRE that the patient experienced during the study period. In total, 482 patients were included. The number of inpatient stays increased from baseline by a mean of 0.52 (standard deviation [SD] 1.17) stays per radiation to bone event and the duration of stays increased by a mean of 7.8 (SD 14.8) days. Outpatient visits increased by a mean of 4.24 (SD 6.57) visits and procedures by a mean of 8.51 (SD 7.46) procedures. HRU increased following radiation to bone across all countries studied. Agents that prevent severe pain and delay the need for radiation have the potential to reduce the burden imposed on healthcare resources and patients.

ACS Style

Roger von Moos; Jean-Jacques Body; Oliver Guenther; Evangelos Terpos; Yves Pascal Acklin; Jindrich Finek; João Pereira; Nikos Maniadakis; Guy Hechmati; Susan Talbot; Harm Sleeboom. Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study. Journal of Bone Oncology 2018, 10, 49 -56.

AMA Style

Roger von Moos, Jean-Jacques Body, Oliver Guenther, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, João Pereira, Nikos Maniadakis, Guy Hechmati, Susan Talbot, Harm Sleeboom. Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study. Journal of Bone Oncology. 2018; 10 ():49-56.

Chicago/Turabian Style

Roger von Moos; Jean-Jacques Body; Oliver Guenther; Evangelos Terpos; Yves Pascal Acklin; Jindrich Finek; João Pereira; Nikos Maniadakis; Guy Hechmati; Susan Talbot; Harm Sleeboom. 2018. "Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study." Journal of Bone Oncology 10, no. : 49-56.